Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Power Wheelchair Medical Necessity for ALS Patients

Mobility Limitations and Medical Necessity

  • The American Heart Association confirms that wheelchairs should be used for nonambulatory individuals or those with limited walking ability, such as patients with progressive ALS, who cannot accomplish daily activities without mobility assistance 2
  • Progressive ALS causes sufficient weakness that patients cannot accomplish toileting, feeding, dressing, grooming, and bathing without mobility assistance, meeting the criterion for mobility limitation significantly impairing MRADLs 1, 2
  • The patient's occupational therapist documented that current mobility limitations prevent timely access to ADLs in the home environment, further supporting the medical necessity of a power wheelchair 1, 2

Power Positioning Features and Complex Seating Needs

  • Power positioning system is essential for maximum sitting tolerance and pressure relief in patients with progressive neuromuscular disease, such as ALS 3
  • The American College of Surgeons confirms that positioning wheelchair backs and specialized cushions are essential for pressure management in wheelchair users, including those with ALS 3
  • Seat elevation and anterior tilt directly enable safer transfers, which is essential for toileting and other MRADLs, as demonstrated in clinical trials 1, 2

Quality of Life and Morbidity Prevention

  • Appropriate wheelchair prescription, including power positioning features, increases participation and improves quality of life in community-dwelling individuals with ALS 3
  • Power positioning prevents pressure ulcers, which in wheelchair-dependent patients can progress to osteomyelitis, sepsis, or require amputation, highlighting the medical necessity of this feature 3
  • Independent mobility within the home maintains dignity and reduces caregiver burden in patients with progressive terminal illnesses like ALS 1, 2